poliomyelitis
poliomyelitis
Explore linked clinical trials. Standard reference: MONDO:001737320 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 1 | 2026-09-29 | NCT07688369 | |
| Effects of Virtual Walking on Chronic Pain and Psychological Distress for Individuals With Severe Mobility Impairment | Chronic Pain, Infections, Neuroinflammatory Diseases, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, RNA Virus Infections, Signs and Symptoms, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, injury, myelitis, nervous system disorder, nervous system injury, neuromuscular disease, poliomyelitis, spinal cord disorder, spinal cord injury, viral infectious disease | Active, not recruiting | Not applicable | 2026-09-15 | NCT07820618 | |
| A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 3 | 2026-09-09 | NCT07010822 | |
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-03 | NCT06947499 | |
| Study of BK1803 in Healthy Infants | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 3 | 2026-08-28 | NCT07793513 | |
| A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-06 | NCT06577298 | |
| Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-05-11 | NCT05654467 | |
| Nomad P-KAFO Study | CNS demyelinating autoimmune disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infections, Muscular Disorders, Atrophic, Neuroinflammatory Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, RNA Virus Infections, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, cerebrovascular disorder, demyelinating disease, enterovirus infectious disease, hereditary disease, immune system disorder, injury, multiple sclerosis, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myelitis, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, palsy, poliomyelitis, postpoliomyelitis syndrome, spinal cord disorder, spinal cord injury, stroke disorder, vascular disorder, viral infectious disease | Recruiting | Not applicable | 2026-05-11 | NCT05644522 | |
| Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Charcot-Marie-Tooth disease, Chronic Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Infections, Lambert-Eaton myasthenic syndrome, Lysosomal Storage Diseases, Nervous System, Muscular Disorders, Atrophic, Neoplasms by Site, Neuroinflammatory Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Picornaviridae infectious disease, RNA Virus Infections, TDP-43 proteinopathy, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, autonomic nervous system disorder, brain disorder, central nervous system disorder, central nervous system infectious disorder, central nervous system malformation, centronuclear myopathy, chronic inflammatory demyelinating polyradiculoneuropathy, congenital structural myopathy, demyelinating disease, disorder of glycogen metabolism, enterovirus infectious disease, facioscapulohumeral muscular dystrophy, glycogen storage disease II, hereditary disease, hereditary motor and sensory neuropathy, hereditary spastic paraplegia, immune system disorder, inborn carbohydrate metabolic disorder, inborn errors of metabolism, inborn mitochondrial metabolism disorder, inborn mitochondrial myopathy, inclusion body myositis, inherited neurodegenerative disorder, lateral sclerosis, lysosomal storage disease, metabolic disease, motor neuron disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myasthenia gravis, myelitis, myositis disease, nemaline myopathy, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, orthostatic intolerance, paraneoplastic syndrome, peripheral nervous system disorder, poliomyelitis, polyneuropathy, polyradiculoneuropathy, postpoliomyelitis syndrome, primary dysautonomia, progressive muscular atrophy, proteostasis deficiencies, spinal cord disorder, spinal muscular atrophy, viral infectious disease | Recruiting | Not applicable | 2026-03-17 | NCT07478172 | |
| Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 4 | 2026-03-09 | NCT07457060 | |
| Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 4 | 2026-01-21 | NCT07354269 | |
| the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines | Digestive System Diseases, Infections, Mononegavirales infectious disease, Neuroinflammatory Diseases, Paramyxoviridae infectious disease, Picornaviridae infectious disease, RNA Virus Infections, Rubivirus Infections, Stomatognathic Diseases, Togaviridae infectious disease, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, measles, morbillivirus infectious disease, mouth disorder, mumps infectious disease, myelitis, nervous system disorder, neuromuscular disease, parotid disorder, parotitis, poliomyelitis, rubella, salivary gland disorder, spinal cord disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Not stated | 2026-01-14 | NCT07338851 | |
| Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 2 | 2026-01-09 | NCT06895486 | |
| Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2025-06-03 | NCT06137664 | |
| Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis | Infections, Muscular Disorders, Atrophic, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, arthritic joint disease, arthropathy, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, injury, muscle tissue disorder, musculoskeletal system disorder, myelitis, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, poliomyelitis, postpoliomyelitis syndrome, spinal cord disorder, spinal cord injury, viral infectious disease | Active, not recruiting | Not applicable | 2025-05-01 | NCT02089880 | |
| Study of Concomitant Administration of the sIPV and DTaP or MMR | Bacterial Infections and Mycoses, Clostridium infectious disease, Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral infectious disease | Not yet recruiting | Phase 4 | 2025-04-17 | NCT06920069 | |
| A Tool Kit to Improve Vaccine Confidence in the Philippines | Infections, Mononegavirales infectious disease, Neuroinflammatory Diseases, Paramyxoviridae infectious disease, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, measles, morbillivirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Active, not recruiting | Not applicable | 2025-03-11 | NCT06218368 | |
| Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV) | Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral infectious disease | Not yet recruiting | Phase 4 | 2024-12-27 | NCT06748612 | |
| Phase IV Study of Concomitant Administration of the sIPV and HepA | Digestive System Diseases, Infections, Neuroinflammatory Diseases, Picornaviridae infectious disease, RNA Virus Infections, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, hepatitis, hepatitis A virus infection, liver disorder, myelitis, nervous system disorder, neuromuscular disease, poliomyelitis, spinal cord disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 4 | 2024-06-14 | NCT06460545 | |
| Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis | Infections, Muscular Disorders, Atrophic, Neuroinflammatory Diseases, Nutritional and Metabolic Diseases, Picornaviridae infectious disease, RNA Virus Infections, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, central nervous system infectious disorder, enterovirus infectious disease, metabolic disease, motor neuron disorder, muscle tissue disorder, musculoskeletal system disorder, myelitis, nervous system disorder, neurodegenerative disease, neuromuscular disease, poliomyelitis, postpoliomyelitis syndrome, proteostasis deficiencies, spinal cord disorder, spinal muscular atrophy, viral infectious disease | Recruiting | Not stated | 2022-12-23 | NCT05663008 |